These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

660 related articles for article (PubMed ID: 29557052)

  • 1. Maturation of Pluripotent Stem Cell-Derived Cardiomyocytes: a Critical Step for Drug Development and Cell Therapy.
    Tan SH; Ye L
    J Cardiovasc Transl Res; 2018 Oct; 11(5):375-392. PubMed ID: 29557052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiomyocytes from human pluripotent stem cells: From laboratory curiosity to industrial biomedical platform.
    Denning C; Borgdorff V; Crutchley J; Firth KS; George V; Kalra S; Kondrashov A; Hoang MD; Mosqueira D; Patel A; Prodanov L; Rajamohan D; Skarnes WC; Smith JG; Young LE
    Biochim Biophys Acta; 2016 Jul; 1863(7 Pt B):1728-48. PubMed ID: 26524115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advancing Cardiovascular Drug Screening Using Human Pluripotent Stem Cell-Derived Cardiomyocytes.
    Oh J; Kwon OB; Park SW; Kim JW; Lee H; Kim YK; Choi EJ; Jung H; Choi DK; Oh BJ; Min SH
    Int J Mol Sci; 2024 Jul; 25(14):. PubMed ID: 39063213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effective Hypothermic Storage of Human Pluripotent Stem Cell-Derived Cardiomyocytes Compatible With Global Distribution of Cells for Clinical Applications and Toxicology Testing.
    Correia C; Koshkin A; Carido M; Espinha N; Šarić T; Lima PA; Serra M; Alves PM
    Stem Cells Transl Med; 2016 May; 5(5):658-69. PubMed ID: 27025693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pluripotent Stem Cell-Based Platforms in Cardiac Disease Modeling and Drug Testing.
    Shaheen N; Shiti A; Gepstein L
    Clin Pharmacol Ther; 2017 Aug; 102(2):203-208. PubMed ID: 28718902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Engineered Maturation Approaches of Human Pluripotent Stem Cell-Derived Ventricular Cardiomyocytes.
    Ge F; Wang Z; Xi JJ
    Cells; 2019 Dec; 9(1):. PubMed ID: 31861463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current Strategies and Challenges for Purification of Cardiomyocytes Derived from Human Pluripotent Stem Cells.
    Ban K; Bae S; Yoon YS
    Theranostics; 2017; 7(7):2067-2077. PubMed ID: 28638487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating the utility of cardiomyocytes from human pluripotent stem cells for drug screening.
    Dick E; Rajamohan D; Ronksley J; Denning C
    Biochem Soc Trans; 2010 Aug; 38(4):1037-45. PubMed ID: 20659000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancing Maturation and Translatability of Human Pluripotent Stem Cell-Derived Cardiomyocytes through a Novel Medium Containing Acetyl-CoA Carboxylase 2 Inhibitor.
    Correia C; Christoffersson J; Tejedor S; El-Haou S; Matadamas-Guzman M; Nair S; Dönnes P; Musa G; Rohman M; Sundqvist M; Riddle RB; Nugraha B; Bellido IS; Johansson M; Wang QD; Hidalgo A; Jennbacken K; Synnergren J; Später D
    Cells; 2024 Aug; 13(16):. PubMed ID: 39195229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Developmental cues for the maturation of metabolic, electrophysiological and calcium handling properties of human pluripotent stem cell-derived cardiomyocytes.
    Keung W; Boheler KR; Li RA
    Stem Cell Res Ther; 2014 Jan; 5(1):17. PubMed ID: 24467782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Universal and Robust Integrated Platform for the Scalable Production of Human Cardiomyocytes From Pluripotent Stem Cells.
    Fonoudi H; Ansari H; Abbasalizadeh S; Larijani MR; Kiani S; Hashemizadeh S; Zarchi AS; Bosman A; Blue GM; Pahlavan S; Perry M; Orr Y; Mayorchak Y; Vandenberg J; Talkhabi M; Winlaw DS; Harvey RP; Aghdami N; Baharvand H
    Stem Cells Transl Med; 2015 Dec; 4(12):1482-94. PubMed ID: 26511653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional improvement and maturation of human cardiomyocytes derived from human pluripotent stem cells by barbaloin preconditioning.
    Yang H; Zhong W; Hamidi MR; Zhou G; Liu C
    Acta Biochim Biophys Sin (Shanghai); 2019 Sep; 51(10):1041-1048. PubMed ID: 31518384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Probing flecainide block of I
    Geng L; Kong CW; Wong AOT; Shum AM; Chow MZY; Che H; Zhang C; Yau KL; Chan CW; Keung W; Li RA
    Toxicol Lett; 2018 Sep; 294():61-72. PubMed ID: 29758359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic environment in vivo as a blueprint for differentiation and maturation of human stem cell-derived cardiomyocytes.
    Slaats RH; Schwach V; Passier R
    Biochim Biophys Acta Mol Basis Dis; 2020 Oct; 1866(10):165881. PubMed ID: 32562698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Promotion of maturation of human pluripotent stem cell-derived cardiomyocytes via treatment with the peroxisome proliferator-activated receptor alpha agonist Fenofibrate.
    Lee SG; Rhee J; Seok J; Kim J; Kim MW; Song GE; Park S; Jeong KS; Lee S; Lee YH; Jeong Y; Kim CY; Chung HM
    Stem Cells Transl Med; 2024 Aug; 13(8):750-762. PubMed ID: 38946019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of Human Pluripotent Stem Cell Derived-Cardiomyocytes to Study Drug-Induced Cardiotoxicity.
    Maillet A; Tan KP; Brunham LR
    Curr Protoc Toxicol; 2017 Aug; 73():22.5.1-22.5.22. PubMed ID: 28777443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-mediated maturation of human pluripotent stem cell-derived cardiomyocytes: Towards a better model for cardiotoxicity?
    White MC; Pang L; Yang X
    Food Chem Toxicol; 2016 Dec; 98(Pt A):17-24. PubMed ID: 27265266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Engineering adolescence: maturation of human pluripotent stem cell-derived cardiomyocytes.
    Yang X; Pabon L; Murry CE
    Circ Res; 2014 Jan; 114(3):511-23. PubMed ID: 24481842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Moving beyond the comprehensive in vitro proarrhythmia assay: Use of human-induced pluripotent stem cell-derived cardiomyocytes to assess contractile effects associated with drug-induced structural cardiotoxicity.
    Yang X; Papoian T
    J Appl Toxicol; 2018 Sep; 38(9):1166-1176. PubMed ID: 29484688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic Maturation of Human Pluripotent Stem Cell-Derived Cardiomyocytes by Inhibition of HIF1α and LDHA.
    Hu D; Linders A; Yamak A; Correia C; Kijlstra JD; Garakani A; Xiao L; Milan DJ; van der Meer P; Serra M; Alves PM; Domian IJ
    Circ Res; 2018 Oct; 123(9):1066-1079. PubMed ID: 30355156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.